πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 23 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12383516

Albuterol aerosol suspension formulation for oral inhalation with high amount of green pro

Amphastar Pharmaceuticals, Inc. Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12350245

Stable oral suspensions of baclofen

ANI Pharmaceuticals, Inc. Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12201639

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. Β· Granted Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11857524

Stable oral suspensions of baclofen

ANI Pharmaceuticals, Inc. Β· Granted Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11471471

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. Β· Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11382922

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. Β· Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11103472

Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)

Infirst Healthcare Limited Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10463674

Process for manufacturing sterile ophthalmic pharmaceutical suspensions

SENTISS PHARMA PRIVATE LIMITED Β· Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10226426

Suspension containing nano-cocrystal and manufacturing method

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9849100

Pharmaceutical compositions suitable for parenteral administration comprising aqueous susp

KalVista Pharmaceuticals Limited Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9731037

Scanning suspension comprising a particle with a diameter of at least 1 micrometer

Universitair Medisch Centrum Utrecht Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9062288

Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes

Regeneus LTD Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8974801

Long term sustained release pharmaceutical composition containing aqueous suspension of bi

Amphastar Pharmaceuticals, Inc. Β· Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779094

Low viscosity highly concentrated suspensions

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697048

Peptide amphiphile suspension to prevent or reduce tumor formation from administered embry

Northwestern University Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8632751

Scanning suspension comprising a particle with a diameter of at least 1 micrometer

Universitair Medisch Centrum Utrecht Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8633034

Methods for evaluating the aggregation of a protein in a suspension including organopolysi

The Regents of the University of Colorado Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8481516

Ciclesonide containing sterile aqueous suspension

TAKEDA GMBH Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367734

Stable epinephrine suspension formulation with high inhalation delivery efficiency

Amphastar Pharmaceuticals, Inc. Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7238366

Submicron liposome suspensions obtained from preliposome lyophilizates

The Board of Regents of the University of Texas System Β· Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7192546

Methods of forming shaped articles from suspensions

Albright & Wilson (Australia) Limited Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7053125

Controlled dispersion of colloidal suspension by comb polymers

W.R. Grace & Co.-Conn. Β· Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6589507

Foaming antacid suspension tablets

DR. Regenold GmbH Β· Granted Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired